Oncogenic signaling pathways and hallmarks of cancer in Korean patients with acral melanoma

被引:0
|
作者
Moon, SeongRyeol [1 ]
Kim, Hee Joo [2 ]
Lee, Yeeun [1 ]
Lee, Yu Joo [4 ]
Jung, Sungwon [3 ,4 ]
Lee, Jin Sook [4 ,5 ]
Hahn, Si Houn [5 ]
Kim, Kyungdoc [6 ]
Roh, Joo Young [7 ]
Nam, Seungyoon [1 ,3 ,8 ,9 ]
机构
[1] Gachon Univ, Gachon Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Incheon 21999, South Korea
[2] Gachon Univ, Coll Med, Dept Dermatol, Gil Med Ctr, Incheon 21565, South Korea
[3] Gachon Univ, Coll Med, Gachon Inst Genome Med & Sci, Dept Genome Med & Sci,Gil Med Ctr, Incheon 21565, South Korea
[4] Seoul Natl Univ Childrens Hosp, Hosp Child Canc & Rare Dis Adm, Dept Pediat, Seoul 03080, South Korea
[5] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Div Genet Med,Sch Med, Seattle, WA 98105 USA
[6] VUNO Inc, Seoul 06536, South Korea
[7] Ewha Womans Univ, Seoul Hosp, Dept Dermatol, Coll Med, 260 Gonghang Daero, Seoul 07804, South Korea
[8] Gachon Univ, AI Convergence Ctr Med Sci, Coll Med, Incheon 21565, South Korea
[9] Gachon Univ, Coll Med, Dokjeom Ro 3Beon-gil, 38-13, Incheon 21565, South Korea
关键词
Acral melanoma; Whole exome sequencing; RNA-Seq; Signaling pathways; MUTATIONS; LANDSCAPE; THERAPY; SIGNATURES; DISCOVERY;
D O I
10.1016/j.compbiomed.2023.106602
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Acral melanoma (AM), a rare subtype of cutaneous melanoma, shows higher incidence in Asians, including Koreans, than in Caucasians. However, the genetic modification associated with AM in Koreans is not well known and has not been comprehensively investigated in terms of oncogenic signaling, and hallmarks of cancer. We performed whole-exome and RNA sequencing for Korean patients with AM and acquired the genetic alterations and gene expression profiles. KIT alterations (previously known to be recurrent alterations in AM) and CDK4/ CCND1 copy number amplifications were identified in the patients. Genetic and transcriptomic alterations in patients with AM were functionally converge to the hallmarks of cancer and oncogenic pathways, including 'proliferative signal persistence', 'apoptotic resistance', and 'activation of invasion and metastasis', despite the heterogeneous somatic mutation profiles of Korean patients with AM. This study may provide a molecular un-derstanding for therapeutic strategy for AM.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer
    White, Mark A.
    Lin, Chenchu
    Rajapakshe, Kimal
    Dong, Jianrong
    Shi, Yan
    Tsouko, Efrosini
    Mukhopadhyay, Ratna
    Jasso, Diana
    Dawood, Wajahat
    Coarfa, Cristian
    Frigo, Daniel E.
    [J]. MOLECULAR CANCER RESEARCH, 2017, 15 (08) : 1017 - 1028
  • [22] Translational control by oncogenic signaling pathways
    Gao, Beichen
    Roux, Philippe P.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2015, 1849 (07): : 753 - 765
  • [23] Crosstalk of oncogenic and prostanoid signaling pathways
    Rolf Müller
    [J]. Journal of Cancer Research and Clinical Oncology, 2004, 130 : 429 - 444
  • [24] Crosstalk of oncogenic and prostanoid signaling pathways
    Müller, R
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (08) : 429 - 444
  • [25] Therapeutic Chemoresistance in Ovarian Cancer: Emerging <break/>Hallmarks, Signaling Mechanisms and Alternative Pathways
    Zaib, Sumera
    Javed, Hira
    Rana, Nehal
    Zaib, Zainab
    Iqbal, Shahid
    Khan, Imtiaz
    [J]. CURRENT MEDICINAL CHEMISTRY, 2024,
  • [26] Upregulated Apelin Signaling in Pancreatic Cancer Activates Oncogenic Signaling Pathways to Promote Tumor Development
    Chaves-Almagro, Carline
    Auriau, Johanna
    Dortignac, Alizee
    Clerc, Pascal
    Lulka, Hubert
    Deleruyelle, Simon
    Projetti, Fabrice
    Nakhle, Jessica
    Frances, Audrey
    Berta, Judit
    Gigoux, Veronique
    Fourmy, Daniel
    Dufresne, Marlene
    Gomez-Brouchet, Anne
    Guillermet-Guibert, Julie
    Cordelier, Pierre
    Knibiehler, Bernard
    Jockers, Ralf
    Valet, Philippe
    Audigier, Yves
    Masri, Bernard
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [27] miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma
    Bennett, Paige E.
    Bemis, Lynne
    Norris, David A.
    Shellman, Yiqun G.
    [J]. PHYSIOLOGICAL GENOMICS, 2013, 45 (22) : 1049 - 1059
  • [28] Tumor growth rate as a prognostic factor of acral melanoma in a Korean population
    Jo, Gwanghyun
    Cho, Soo Ick
    Cho, Youngjoo
    Ohn, Jungyoon
    Mun, Je-Ho
    [J]. MEDICINE, 2020, 99 (21) : E19936
  • [29] Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study
    Hong, Jin-Woo
    Lee, Suee
    Kim, Dae-Cheol
    Kim, Ki-Ho
    Song, Ki-Hoon
    [J]. ANNALS OF DERMATOLOGY, 2014, 26 (02) : 195 - 202
  • [30] Chemokine Receptor Signaling and the Hallmarks of Cancer
    Lacalle, R. A.
    Blanco, R.
    Carmona-Rodriguez, L.
    Martin-Leal, A.
    Mira, E.
    Manes, S.
    [J]. INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 331, 2017, 331 : 181 - 244